Indogulf Cropsciences Ltd (IGCL) — concall transcript | 30 June 2026(2 announcements)

· BSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
1 concall transcript 🟡 Notable Neutral 📄 PDF

No summary available

2 concall transcript 🟡 Notable Neutral 📄 PDF
📢 Key Event
Q1 FY27 earnings call transcript released on August 18, 2026
🔄 What Changed
Gross margin improved to 28% (from 22% YoY) and EBITDA margin to 5.7% (from 5.2%), driven by cost discipline and product mix; capacity utilization at 70% with expansion to Rs 1800 crores over 4-5 years
🔮 What's Next
No specific FY27 growth target given; capacity expansion to Rs 1800 crores over 4-5 years; new registrations in Saudi Arabia; biologicals segment targeting mid-term growth
💡 Investor Takeaway
The company is building long-term value through higher-margin products and global expansion, but near-term growth remains constrained by monsoon and pricing pressures

Indogulf Cropsciences Ltd reported Q1 FY27 revenue of ₹168.5 crores, down 11% YoY, with gross margin expanding to 28% and EBITDA margin to 5.7% despite delayed monsoons and pricing pressure. Management highlighted capacity utilization at 70%, ongoing international expansion, and a strategic shift toward higher-value products like biologicals, which now represent 22% of revenue. CAPEX plans include scaling capacity to Rs 1800 crores over 4-5 years. The company remains cautious on monsoon outlook but sees long-term export opportunities.

About Indogulf Cropsciences Ltd (IGCL)

Chemicals · Agro Chemicals · Listed on BSE

Market Cap: ₹450.22 Cr P/E: 13.8 ROE: 14.0% ROCE: 14.0%

View full IGCL stock details →

📡 Get AI alerts when IGCL files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track IGCL — Free

📊 More IGCL filings

See all IGCL filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when IGCL files new disclosures

Track IGCL filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track IGCL — Free

Free account · 2 AI queries/day